等待開盤 09-20 09:30:00 美东时间
+0.220
+3.90%
RBC Capital analyst Leonid Timashev reiterates Design Therapeutics (NASDAQ:DSGN) with a Sector Perform and maintains $4 price target.
08-06 20:52
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-06 20:51
Design Therapeutics Inc : Leerink Partners Raises Target Price to $5.00 From $4...
08-06 12:38
Design Therapeutics (NASDAQ:DSGN) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.23) by 8.7 percent. This is a 41.67 percent increase over losses of $(0.36) per share from
08-05 20:17
Design Therapeutics: Cash, Cash Equivalents & Marketable Securities as of J...
08-05 20:02
Design Therapeutics Q2 Operating Income USD -15.043 Million
08-05 20:00
Design Therapeutics Q2 Net Income USD -11.793 Million
08-05 20:00
Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews...
08-05 20:00
Shares of Lexeo Therapeutics (NASDAQ:LXEO) tumbled 24% after the company reported interim Phase 1/2 clinical data for its drug LX2006 for the treatment of Friedreich Ataxia, or FA, cardiomyopathy. Lex...
07-16 00:03
Just because a business does not make any money, does not mean that the stock w...
07-12 21:22